Xcel Brands (XELB) 10-Q 11 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 05, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Registrant Name	XCel Brands, Inc.
Entity Central Index Key	1,083,220
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	XELB
Entity Common Stock, Shares Outstanding		18,447,692

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents	$ 10,201	$ 14,127
Accounts receivable, net	8,706	6,969
Prepaid expenses and other current assets	887	807
Total current assets	19,794	21,903
Property and equipment, net	2,624	2,600
Trademarks and other intangibles, net	110,955	111,220
Goodwill	12,371	12,371
Restricted cash	1,509	1,509
Other assets	1,514	1,517
Total non-current assets	128,973	129,217
Total Assets	148,767	151,120
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	2,228	1,523
Accrued payroll	833	2,185
Deferred revenue	75	234
Current portion of long-term debt	6,193	6,427
Total current liabilities	9,329	10,369
Long-Term Liabilities:
Long-term debt, less current portion	23,817	25,495
Deferred tax liabilities, net	7,357	6,901
Other long-term liabilities	2,202	2,181
Total long-term liabilities	33,376	34,577
Total Liabilities	42,705	44,946
Commitments and Contingencies
Stockholders' Equity:
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding	0	0
Common stock, $.001 par value, 35,000,000 shares authorized at March 31, 2017 and December 31, 2016, and 18,447,692 and 18,644,982 issued and outstanding at March 31, 2017 and December 31, 2016, respectively	18	19
Paid-in capital	97,642	97,354
Retained earnings	8,402	8,801
Total Stockholders' Equity	106,062	106,174
Total Liabilities and Stockholders' Equity	$ 148,767	$ 151,120

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	35,000,000	35,000,000
Common stock, shares issued	18,447,692	18,644,982
Common stock, shares outstanding	18,447,692	18,644,982

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues
Net revenues	$ 8,430	$ 8,361
Operating costs and expenses
Salaries, benefits and employment taxes	4,367	4,210
Other design and marketing costs	871	829
Other selling, general and administrative expenses	1,280	1,345
Stock-based compensation	1,083	1,212
Depreciation and amortization	394	426
Total operating costs and expenses	7,995	8,022
Operating income
Operating income	435	339
Interest and finance expense
Interest expense - term debt	328	311
Other interest and finance charges	50	124
Total interest and finance expense	378	435
Income (loss) before income taxes	57	(96)
Income tax provision (benefit)	456	(51)
Net loss	$ (399)	$ (45)
Basic and diluted loss per share:
Basic and diluted net loss per share	$ (0.02)	$ 0
Basic and diluted weighted average common shares outstanding (in shares)	18,674,943	18,458,748

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities
Net loss	$ (399)	$ (45)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	394	426
Amortization of deferred finance costs	50	46
Stock-based compensation	1,083	1,212
Amortization of note discount	9	80
Deferred income tax provision (benefit)	456	(51)
Changes in operating assets and liabilities:
Accounts receivable	(1,737)	(1,534)
Prepaid expenses and other assets	(83)	(66)
Accounts payable, accrued expenses and other current liabilities	(647)	(1,110)
Deferred revenue	(159)	(557)
Other liabilities	21	297
Net cash used in operating activities	(1,012)	(1,302)
Cash flows from investing activities
Cost to acquire intangible assets	(18)	0
Purchase of property and equipment	(135)	(246)
Net cash used in investing activities	(153)	(246)
Cash flows from financing activities
Proceeds from exercise of stock options and warrants	0	20
Shares repurchased including vested restricted stock in exchange for withholding taxes	(795)	(302)
Payment of deferred finance costs	(7)	(69)
Payment of long-term debt	(1,959)	(2,125)
Payment of earn-out obligations	0	(250)
Net cash used in financing activities	(2,761)	(2,726)
Net decrease in cash, cash equivalents, and restricted cash	(3,926)	(4,274)
Cash, cash equivalents, and restricted cash at beginning of period	15,636	17,969
Cash, cash equivalents, and restricted cash at end of period	11,710	13,695
Reconciliation to amounts on consolidated balance sheets:
Cash and cash equivalents	10,201	12,586
Restricted cash	1,509	1,109
Total cash, cash equivalents, and restricted cash	11,710	13,695
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes	110	112
Cash paid during the period for interest	$ 370	$ 270

Nature of Operations, Backgroun

Nature of Operations, Background, and Basis of Presentation	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Nature of Operations, Background, and Basis of Presentation The accompanying condensed balance sheet as of December 31, 2016 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company”). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the SEC on March 24, 2017. The Company is a media and brand management company engaged in the design, production, licensing, marketing, and direct to consumer sales of branded apparel, footwear, accessories, jewelry, home goods, and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Currently, the Company’s brand portfolio consists of the Isaac Mizrahi brand (the "Isaac Mizrahi Brand"), the Judith Ripka brand (the “Ripka Brand”), the H by Halston and H Halston brands (collectively, the “H Halston Brands”), the C Wonder brand (the “C Wonder Brand”), and the Highline Collective brand. The Company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements with manufacturers and retailers. These activities include licensing its own brands for promotion and distribution through a ubiquitous retail sales strategy, which encompasses distribution through interactive television, the internet, and traditional brick-and-mortar retail channels. Certain reclassifications have been made to the prior period unaudited condensed consolidated financial statements to conform to the current period presentation, including: · Presentation of e-commerce gross margin within total net revenues on the condensed consolidated statements of operations. Of the $ 70,000 31,000 39,000 · Presentation of restricted cash on the condensed consolidated statements of cash flows, as a result of the early adoption of Accounting Standards Update No. 2016-18 in the fourth quarter of 2016. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

Trademarks, Goodwill and Other

Trademarks, Goodwill and Other Intangibles	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	2. Trademarks, Goodwill and Other Intangibles Trademarks and other intangibles, net consist of the following: March 31, 2017 ($ in thousands) Weighted- Gross Carrying Accumulated Net Carrying Trademarks (indefinite-lived) n/a $ 96,694 $ - $ 96,694 Trademarks (definite-lived) 15 years 15,463 1,716 13,747 Licensing agreements 4 years 2,000 2,000 - Non-compete agreement 7 years 562 181 381 Copyrights and other intellectual property 10 years 190 57 133 Total $ 114,909 $ 3,954 $ 110,955 December 31, 2016 ($ in thousands) Weighted- Gross Carrying Accumulated Net Carrying Trademarks (indefinite-lived) n/a $ 96,676 $ - $ 96,676 Trademarks (definite-lived) 15 years 15,463 1,459 14,004 Licensing agreements 4 years 2,000 2,000 - Non-compete agreement 7 years 562 160 402 Copyrights and other intellectual property 10 years 190 52 138 Total $ 114,891 $ 3,671 $ 111,220 Amortization expense for intangible assets was $283,000 and $282,000 for the quarter ended March 31, 2017 (the “Current Quarter”) and the quarter ended March 31, 2016 (the “Prior Year Quarter”), respectively. The trademarks related to the Isaac Mizrahi Brand, the Ripka Brand, and the H Halston Brands have been determined to have indefinite useful lives, and accordingly no amortization has been recorded for these assets. The Company has $12.371 million of goodwill related to the 2011 acquisition of the Isaac Mizrahi business. There was no change in goodwill during the Current Quarter.

Significant Contracts

Significant Contracts	3 Months Ended
	Mar. 31, 2017
Significant Contracts [Abstract]
Significant Contracts [Text Block]	3. Significant Contracts QVC Agreements Under the Company’s agreements with QVC, QVC is required to pay the Company fees based primarily on a percentage of its net sales of Isaac Mizrahi, Ripka, H Halston, and C Wonder branded merchandise. QVC royalty revenue represents a significant portion of the Company’s total revenues. Revenues from QVC totaled $ 7.30 7.31 87 87 7.25 5.89 83 85

Debt

Debt	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	4. Debt March 31, December 31, ($ in thousands) 2017 2016 Xcel Term Loan $ 24,000 $ 25,250 Unamortized deferred finance costs related to term loan (472) (509) IM Seller Note 2,918 3,627 Ripka Seller Notes 514 504 Contingent obligation - JR Seller 200 200 Contingent obligation - CW Seller 2,850 2,850 Total 30,010 31,922 Current portion (i) 6,193 6,427 Long-term debt $ 23,817 $ 25,495 (i) The current portion of long-term debt as of March 31, 2017 consists of (a) $ 4.750 1.443 Xcel Term Loan On February 26, 2016, Xcel and its wholly owned subsidiaries, IM Brands, LLC, JR Licensing, LLC, H Licensing, LLC, C Wonder Licensing, LLC, Xcel Design Group, LLC, IMNY Retail Management, LLC, and IMNY E-Store, USA, LLC (each a “Guarantor” and collectively, the “Guarantors”), as Guarantors, entered into an Amended and Restated Loan and Security Agreement (the “Loan Agreement”) with Bank Hapoalim B.M. (“BHI”), as agent (the “Agent”), and the financial institutions party thereto as lenders (the “Lenders”). The Loan Agreement amended and restated the IM Term Loan, the JR Term Loan, and the H Term Loan. Pursuant to the Loan Agreement, Xcel assumed the obligations of each of IM Brands, LLC, JR Licensing, LLC, and H Licensing, LLC under the respective term loans with BHI in the aggregate principal amount of $ 27,875,000 On February 24, 2017, Xcel and BHI amended the terms of the Loan Agreement (the “Amended Loan Agreement”). Under this amendment, principal payments for the year ending December 31, 2017 were increased by a total of $ 1,000,000 1,000,000 The Xcel Term Loan matures on January 1, 2021. Principal on the Xcel Term Loan is payable in quarterly installments on each of January 1, April 1, July 1 and October 1. ($ in thousands) Year Ending December 31, Amount of 2017 (April 1 through December 31) $ 3,750 2018 4,000 2019 4,000 2020 4,000 2021 8,250 Total $ 24,000 Under the Amended Loan Agreement, the Company has the right to prepay the Xcel Term Loan, provided that any prepayment of less than all of the outstanding balance shall be applied to the remaining amounts due in inverse order of maturity. If the Xcel Term Loan is prepaid on or prior to the third anniversary of the closing date (including as a result of an event of default), the Company shall pay an early termination fee equal to the principal amount outstanding under the Term Loan on the date of prepayment, multiplied by: (i) two percent (2.00%) if the Xcel Term Loan is prepaid on or after the closing date and on or before the second anniversary of the closing date; or (ii) one percent (1.00%) if the Xcel Term Loan is prepaid after the second anniversary of the closing date and on or before the third anniversary of the closing date. Commencing with the fiscal year ending December 31, 2017, the Company is required to repay a portion of the Xcel Term Loan in an amount equal to 10% of the excess cash flow for the fiscal year; provided that no early termination fee shall be payable with respect to any such payment. Excess cash flow means, for any period, cash flow from operations (before certain permitted distributions) less (i) capital expenditures not made through the incurrence of indebtedness, (ii) all cash interest and principal and taxes paid or payable during such period, and (iii) all dividends declared and paid during such period to equity holders of any credit party treated as a disregarded entity for tax purposes. Xcel’s obligations under the Amended Loan Agreement are guaranteed by the Guarantors and secured by all of the assets of Xcel and the Guarantors (as well as any subsidiary formed or acquired that becomes a credit party to the Amended Loan Agreement) and, subject to certain limitations contained in the Amended Loan Agreement, equity interests of the Guarantors (as well as any subsidiary formed or acquired that becomes a credit party to the Amended Loan Agreement). The Amended Loan Agreement contains customary covenants, including reporting requirements, trademark preservation, and the following financial covenants of the Company (on a consolidated basis with the Guarantors and any subsidiaries subsequently formed or acquired that become a credit party under the Amended Loan Agreement): · net worth (as defined in the Amended Loan Agreement) of at least $ 90,000,000 · liquid assets of at least $ 5,000,000 1.00 3,000,000 · a fixed charge ratio of at least 1.20 1.00 · capital expenditures shall not exceed (i) $ 2,650,000 700,000 · EBITDA (as defined in the Amended Loan Agreement) of $ 9,000,000 The Company was in compliance with all applicable covenants as of March 31, 2017. Interest on the Xcel Term Loan accrues at a fixed rate of 5.1 308,000 310,000 IM Seller Note On September 29, 2011, as part of the consideration for the purchase of the Isaac Mizrahi Business, the Company issued to IM Ready-Made, LLC (“IM Ready”) a promissory note in the principal amount of $ 7,377,000 0.25 9.25 1,740,000 9.0 5,637,000 123,000 On December 24, 2013, the IM Seller Note was amended to (1) revise the maturity date to September 30, 2016, (2) revise the date to which the maturity date may be extended to September 30, 2018, (3) provide the Company with a prepayment right with its common stock, subject to remitting in cash certain required cash payments and a minimum common stock price of $ 4.50 On September 19, 2016, the IM Seller Note was further amended and restated to (1) revise the maturity date to March 31, 2019 ($ in thousands) Amount of Principal Year Ending December 31, Payment 2017 (April 1 through December 31) $ 717 2018 1,459 2019 742 Total $ 2,918 For the Current Quarter, the Company incurred interest expense of $ 20,000 72,000 Ripka Seller Notes On April 3, 2014, as part of the consideration for the purchase of the Ripka Brand, JR Licensing issued to Ripka promissory notes in the aggregate principal amount of $ 6,000,000 7.00 7.00 Management determined that the Company’s expected borrowing rate was estimated to be 7.33 1,835,000 7.33 4,165,000 During 2015, the Company satisfied an aggregate $ 5,400,000 600,001 600,000 For both the Current Quarter and Prior Year Quarter, the Company incurred interest expense of approximately $ 9,000 Contingent Obligation – JR Seller (Ripka Earn-Out) In connection with the purchase of the Ripka Brand, the Company agreed to pay Ripka additional consideration of up to $ 5 7.00 1 3.78 On December 21, 2016, the Company entered into an agreement with the sellers of the Ripka Brand which amended the terms of the Ripka Earn-Out, such that the maximum amount of earn-out consideration was reduced to $ 375,000 175,000 100,000 200,000 6,000,000 3.78 0.38 3.41 Contingent Obligations – CW Seller (C Wonder Earn-Out) In connection with the purchase of the C Wonder Brand, the Company agreed to pay the seller additional consideration (the “C Wonder Earn-Out”), which would be payable, if at all, in cash or shares of common stock of the Company, at the Company’s sole discretion, after June 30, 2019, with a value based on the royalties related directly to the assets the Company acquired pursuant to the purchase agreement. The value of the earn-out shall be calculated as the positive amount, if any, of (i) two times (A) the maximum net royalties as calculated for any single twelve month period commencing on July 1 and ending on June 30 between the closing date and June 30, 2019 (each, a “Royalty Target Year”) less (B) $ 4,000,000 2.85 As of March 31, 2017 and December 31, 2016, total contingent obligations were $ 3.05

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	5. Stockholders’ Equity 2011 Equity Incentive Plan The Company’s 2011 Equity Incentive Plan, as amended and restated (the “Plan”), is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 13,000,000 The fair value of options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, and expected life is based on the estimated average of the life of options and warrants using the simplified method. The Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s). Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. Stock Options Options granted under the Plan expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant. On January 1, 2017, the Company granted options to purchase an aggregate of 150,000 5.50 On January 24, 2017, the Company granted options to purchase an aggregate of 500,000 5.00 On March 31, 2017, the Company granted options to purchase an aggregate of 150,000 2.70 50 Expected Volatility 33.80 – 35.20 % Expected Dividend Yield 0 % Expected Life (Term) 3.25 – 5.42 years Risk-Free Interest Rate 1.55 – 2.02 % Weighted Average Weighted Remaining Average Contractual Aggregate Number of Exercise Life Intrinsic Options Price (in Years) Value Outstanding at January 1, 2017 2,436,000 $ 5.98 4.38 $ - Granted 800,000 4.66 Canceled - - Exercised - - Expired/Forfeited (7,000) 5.80 Outstanding at March 31, 2017, 3,229,000 $ 5.66 4.76 $ - Exercisable at March 31, 2017 811,670 $ 6.01 3.86 $ - Compensation expense related to stock options for the Current Quarter and the Prior Year Quarter was approximately $ 302,000 18,000 3,040,000 2.77 Weighted Average Number of Grant Date Options Fair Value Balance at January 1, 2017 2,294,667 $ 1.39 Granted 800,000 1.09 Vested (670,337) 1.49 Forfeited or Canceled (7,000) 1.49 Balance at March 31, 2017 2,417,330 $ 1.31 Warrants Warrants granted under the Plan expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant. As of March 31, 2017 and December 31, 2016, there were 1,966,743 6.76 2.56 2.81 There were no warrants to purchase shares of common stock granted, canceled, exercised, or expired/forfeited during the Current Quarter. No compensation expense was recognized in the Current Quarter or Prior Year Quarter related to warrants. Restricted Stock On January 31, 2017, the Company issued 50,000 50,000 25,000 25,000 On March 31, 2017, the Company issued to non-management directors an aggregate of 48,000 50 50 Notwithstanding the foregoing, each executive and director grantee may extend the first anniversary of all or a portion of the restricted stock by six months and, thereafter one or more times may further extend such date with respect to all or a portion of the restricted stock until the next following date six months or twelve months hence, by providing written notice of such election to extend such date with respect to all or a portion of the restricted stock prior to such date. Weighted Number of Average Restricted Grant Date Shares Fair Value Outstanding at January 1, 2017 3,171,685 $ 5.12 Granted 98,000 3.29 Canceled - - Vested (683,251) 4.23 Expired/Forfeited (750) 5.80 Outstanding at March 31, 2017 2,585,684 $ 5.28 Compensation expense related to restricted stock grants for the Current Quarter and Prior Year Quarter was $ 781,000 1,194,000 1,530,000 1.68 Shares Available Under the Company’s 2011 Equity Incentive Plan At March 31, 2017, there were 5,532,131 Shares Reserved for Issuance At March 31, 2017, there were 10,727,874 Dividends The Company has not paid any dividends to date.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	6. Earnings Per Share Basic earnings per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Weighted-average basic shares outstanding for the three months ended March 31, 2017 and 2016 were 18,674,943 18,458,748 Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. As a result of the net loss presented for the Current Quarter and Prior Year Quarter, the Company calculated diluted earnings per share using basic weighted-average shares outstanding for those periods, as utilizing diluted shares would be anti-dilutive to loss per share. Three Months Ended March 31, 2017 2016 Stock options and warrants 5,195,743 3,266,500

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	7. Income Tax The effective income tax rate for the Current Quarter and the Prior Year Quarter was approximately 800 53 456,000 (51,000) In the Current Quarter, the effective tax rate was primarily attributable to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes. This item increased the effective rate by 737 29 In the Prior Year Quarter, the effective tax rate was attributable to recurring permanent differences. Based on the amount of loss before income taxes compared to the permanent differences, the effective rate increased by 19

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	8. Related Party Transactions Benjamin Malka Concurrent with the acquisition of the H Halston Brand on December 22, 2014, the Company entered into a license agreement with The H Company IP, LLC (“HIP”), which was subsequently amended September 1, 2015. Benjamin Malka, a director of the Company, is a 25 December 31, 2019 On September 1, 2015, the Company entered into a license agreement with Lord and Taylor, LLC (the “L&T License”) and simultaneously amended the H Halston License Agreement eliminating HIP’s minimum guaranteed royalty obligations, provided the L&T License is in effect. In addition, the Company entered into a sublicense agreement with HIP obligating the Company to pay HIP a fee on an annual basis the greater of (i) 50 1,000,000 0.75 0.75 1.5 1.75 0.19 The Company recorded $ 9,000 34,000 HOH has also entered into an arrangement with another licensee of the Company to supply Halston-branded apparel for the subsequent sale of such product to end customers. Under the Company’s separate pre-existing licensing agreements in place with the aforementioned other licensee and with HIP as described above, the Company earns royalties on the sales of such Halston-branded products. Edward Jones, III During the Current Quarter and Prior Year Quarter, Edward Jones, III, a director of the Company, performed consulting services for and received compensation from a certain licensee of the Company. Under the terms of the Company’s agreement with this certain licensee, the licensee may supply the Company’s branded products to our other licensees. Under the terms of the Company’s separate pre-existing agreements with other licensees, the Company would earn royalties on the sales of such branded products sold to end customers. On January 31, 2017, the Company entered into a two-year consulting agreement (the “QTR Consulting Agreement”) with Jones Texas, Inc. (“JTI”), whose controlling shareholder is Edward Jones, III, a director of the Company, pursuant to which JTI shall cause Mr. Jones to provide consulting services in connection with the Company’s quick-time-response fashion program and other projects. Pursuant to the QTR Consulting Agreement, the Company issued an aggregate of 50,000 25,000 25,000 25,000 28,334 75,000 75,000

Facility Exit Costs

Facility Exit Costs	3 Months Ended
	Mar. 31, 2017
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	9. Facility Exit Costs In June 2016, the Company relocated its corporate offices and operations from 475 Tenth Avenue in New York City to 1333 Broadway in New York City. In connection with the exit from its former office location, the Company recognized a liability at the exit and cease-use date for the remaining lease obligation associated with 475 Tenth Avenue, based on the remaining contractual lease payments less estimated sublease rentals, discounted to present value using a credit-adjusted risk-free rate. The Company recorded a net non-cash charge of approximately $ 648,000 The remaining balance of the exit cost liability related to the former office space was approximately $ 737,000 157,000 580,000 ($ in thousands) Balance as of January 1, 2017 $ 783 Cash payments, net (26) Adjustment to liability (revision to estimated cash flows) (25) Accretion 5 Balance as of March 31, 2017 $ 737

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	10. Subsequent Events On April 28, 2017, the Company and QVC entered into an amendment to terminate the C Wonder QVC Agreement effective May 1, 2017 and commence a sell-off period. During the sell-off period, QVC remains obligated to pay royalties to the Company through January 31, 2018, and QVC retains exclusive rights with respect to C Wonder branded products for interactive television, excluding certain permitted international entities, through May 1, 2018

Trademarks, Goodwill and Othe16

Trademarks, Goodwill and Other Intangibles (Tables)	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	Trademarks and other intangibles, net consist of the following: March 31, 2017 ($ in thousands) Weighted- Gross Carrying Accumulated Net Carrying Trademarks (indefinite-lived) n/a $ 96,694 $ - $ 96,694 Trademarks (definite-lived) 15 years 15,463 1,716 13,747 Licensing agreements 4 years 2,000 2,000 - Non-compete agreement 7 years 562 181 381 Copyrights and other intellectual property 10 years 190 57 133 Total $ 114,909 $ 3,954 $ 110,955 December 31, 2016 ($ in thousands) Weighted- Gross Carrying Accumulated Net Carrying Trademarks (indefinite-lived) n/a $ 96,676 $ - $ 96,676 Trademarks (definite-lived) 15 years 15,463 1,459 14,004 Licensing agreements 4 years 2,000 2,000 - Non-compete agreement 7 years 562 160 402 Copyrights and other intellectual property 10 years 190 52 138 Total $ 114,891 $ 3,671 $ 111,220

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	The Company’s net carrying amount of debt is comprised of the following: March 31, December 31, ($ in thousands) 2017 2016 Xcel Term Loan $ 24,000 $ 25,250 Unamortized deferred finance costs related to term loan (472) (509) IM Seller Note 2,918 3,627 Ripka Seller Notes 514 504 Contingent obligation - JR Seller 200 200 Contingent obligation - CW Seller 2,850 2,850 Total 30,010 31,922 Current portion (i) 6,193 6,427 Long-term debt $ 23,817 $ 25,495 (i) The current portion of long-term debt as of March 31, 2017 consists of (a) $ 4.750 1.443
Schedule of Maturities of Long-term Debt [Table Text Block]	The aggregate remaining annual principal payments under the Amended Loan Agreement are as follows: ($ in thousands) Year Ending December 31, Amount of 2017 (April 1 through December 31) $ 3,750 2018 4,000 2019 4,000 2020 4,000 2021 8,250 Total $ 24,000
Debt Instrument Principal Payments [Table Text Block]	The aggregate remaining annual principal payments under the IM Seller Note are as follows: ($ in thousands) Amount of Principal Year Ending December 31, Payment 2017 (April 1 through December 31) $ 717 2018 1,459 2019 742 Total $ 2,918

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]	The fair values of the options granted during the Current Quarter were estimated at the date of grant using the Black-Scholes option pricing model with the following assumptions: Expected Volatility 33.80 – 35.20 % Expected Dividend Yield 0 % Expected Life (Term) 3.25 – 5.42 years Risk-Free Interest Rate 1.55 – 2.02 %
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of the Company’s stock options activity for the Current Quarter is as follows: Weighted Average Weighted Remaining Average Contractual Aggregate Number of Exercise Life Intrinsic Options Price (in Years) Value Outstanding at January 1, 2017 2,436,000 $ 5.98 4.38 $ - Granted 800,000 4.66 Canceled - - Exercised - - Expired/Forfeited (7,000) 5.80 Outstanding at March 31, 2017, 3,229,000 $ 5.66 4.76 $ - Exercisable at March 31, 2017 811,670 $ 6.01 3.86 $ -
Schedule of Stock Options Roll Forward [Table Text Block]	The following table summarizes the Company’s stock option activity for non-vested options for the Current Quarter: Weighted Average Number of Grant Date Options Fair Value Balance at January 1, 2017 2,294,667 $ 1.39 Granted 800,000 1.09 Vested (670,337) 1.49 Forfeited or Canceled (7,000) 1.49 Balance at March 31, 2017 2,417,330 $ 1.31
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	A summary of the Company’s restricted stock activity for the Current Quarter is as follows: Weighted Number of Average Restricted Grant Date Shares Fair Value Outstanding at January 1, 2017 3,171,685 $ 5.12 Granted 98,000 3.29 Canceled - - Vested (683,251) 4.23 Expired/Forfeited (750) 5.80 Outstanding at March 31, 2017 2,585,684 $ 5.28

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	The computation of diluted EPS excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: Three Months Ended March 31, 2017 2016 Stock options and warrants 5,195,743 3,266,500

Facility Exit Costs (Tables)

Facility Exit Costs (Tables)	3 Months Ended
	Mar. 31, 2017
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs [Table Text Block]	A summary of the activity related to the exit cost liability for the Current Quarter is as follows: ($ in thousands) Balance as of January 1, 2017 $ 783 Cash payments, net (26) Adjustment to liability (revision to estimated cash flows) (25) Accretion 5 Balance as of March 31, 2017 $ 737

Nature of Operations, Backgro21

Nature of Operations, Background, and Basis of Presentation (Details Taxtual)	3 Months Ended
	Mar. 31, 2016USD ($)
Prior Period Reclassification Adjustment	$ 70,000
Sales Revenue, Net [Member]
Prior Period Reclassification Adjustment	31,000
Selling, General and Administrative Expenses [Member]
Prior Period Reclassification Adjustment	$ 39,000

Trademarks, Goodwill and Othe22

Trademarks, Goodwill and Other Intangibles (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Finite and Indefinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, Total	$ 114,909	$ 114,891
Accumulated Amortization	3,954	3,671
Net Carrying Amount, Total	$ 110,955	$ 111,220
Non-compete agreement [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	7 years	7 years
Gross Carrying Amount (definite-lived)	$ 562	$ 562
Accumulated Amortization	181	160
Net Carrying Amount	$ 381	$ 402
Copyrights and other intellectual property [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	10 years	10 years
Gross Carrying Amount (definite-lived)	$ 190	$ 190
Accumulated Amortization	57	52
Net Carrying Amount	$ 133	$ 138
Trademarks [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	15 years	15 years
Gross Carrying Amount (indefinite-lived)	$ 96,694	$ 96,676
Gross Carrying Amount (definite-lived)	15,463	15,463
Accumulated Amortization	1,716	1,459
Net Carrying Amount	13,747	14,004
Net Carrying Amount, Total	$ 96,694	$ 96,676
Licensing agreements [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	4 years	4 years
Gross Carrying Amount (definite-lived)	$ 2,000	$ 2,000
Accumulated Amortization	2,000	2,000
Net Carrying Amount	$ 0	$ 0

Trademarks, Goodwill and Othe23

Trademarks, Goodwill and Other Intangibles (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Research and Development Assets Acquired Other than Through Business Combination [Line Items]
Amortization of Intangible Assets	$ 283,000	$ 282,000
Goodwill	$ 12,371,000		$ 12,371,000

Significant Contracts (Details

Significant Contracts (Details Textual) - Royalty Agreement With QVC [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Business Acquisition [Line Items]
Royalty Revenue	$ 7,300	$ 7,310
Revenue from Royalty, Percentage	87.00%	87.00%
Accounts Receivable, Gross	$ 7,250		$ 5,890
Accounts Receivables, Percentage	83.00%		85.00%

Debt (Details)

Debt (Details) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Unamortized deferred finance costs related to term loans		$ (472)	$ (509)
Total		30,010	31,922
Current portion	[1]	6,193	6,427
Long-term debt		23,817	25,495
Xcel Term Loan [Member]
Debt Instrument [Line Items]
Total		24,000	25,250
IM Seller Note [Member]
Debt Instrument [Line Items]
Seller Note		2,918	3,627
JR Seller [Member]
Debt Instrument [Line Items]
Contingent obligation - due to seller		200	200
Ripka Seller Notes [Member]
Debt Instrument [Line Items]
Seller Note		514	504
CW Seller [Member]
Debt Instrument [Line Items]
Contingent obligation - due to seller		$ 2,850	$ 2,850
[1]	The current portion of long-term debt as of March 31, 2017 consists of (a) $4.750 million related to the Xcel Term Loan and (b) $1.443 million related to the IM Seller Note.

Debt (Details 1)

Debt (Details 1) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Total	$ 30,010	$ 31,922
Xcel Term Loan [Member]
Debt Instrument [Line Items]
2017 (April 1 through December 31)	3,750
2,018	4,000
2,019	4,000
2,020	4,000
2,021	8,250
Total	$ 24,000	$ 25,250

Debt (Details 2)

Debt (Details 2) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Total	$ 30,010	$ 31,922
I M Ready Made L L C [Member]
Debt Instrument [Line Items]
2017 (April 1 through December 31)	717
2,018	1,459
2,019	742
Total	$ 2,918

Debt (Details Textual)

Debt (Details Textual)	1 Months Ended					3 Months Ended				12 Months Ended
	Dec. 21, 2016USD ($)	Sep. 19, 2016	Feb. 26, 2016USD ($)	Dec. 24, 2013$ / shares	Sep. 29, 2011USD ($)	Mar. 31, 2017USD ($)$ / shares	Dec. 31, 2016USD ($)	Jun. 30, 2016USD ($)	Mar. 31, 2016USD ($)	Dec. 31, 2021USD ($)	Mar. 31, 2019USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)shares	May 15, 2019USD ($)	May 15, 2018USD ($)	Dec. 31, 2014USD ($)	Apr. 03, 2014USD ($)$ / shares
Debt Instrument [Line Items]
Long-term Debt, Contingent Payment of Principal or Interest						the Company shall pay an early termination fee equal to the principal amount outstanding under the Term Loan on the date of prepayment, multiplied by: (i) two percent (2.00%) if the Xcel Term Loan is prepaid on or after the closing date and on or before the second anniversary of the closing date; or (ii) one percent (1.00%) if the Xcel Term Loan is prepaid after the second anniversary of the closing date and on or before the third anniversary of the closing date.
Interest Expense, Debt						$ 328,000			$ 311,000
Minimum Liquidity Covenants						3,000,000
Long-term Debt, Total						30,010,000	$ 31,922,000							$ 31,922,000
Repayments of Long-term Debt, Total						1,959,000			2,125,000
Long-term Debt, Current Maturities, Total						6,193,000	$ 6,427,000							6,427,000
Ripka Seller Notes [Member]
Debt Instrument [Line Items]
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate																			7.33%
Debt Instrument, Face Amount																			$ 6,000,000
Debt Instrument, Unamortized Discount																			$ 1,835,000
Imputed Annual Interest Rate																			7.33%
Initial Outstanding Value of Long-term Debt or Borrowing																			$ 4,165,000
Interest Expense, Debt						$ 9,000			9,000
Floor Price Per Share for Conversion of Debt | $ / shares																			$ 7
Repayments of Long-term Debt, Total															$ 5,400,000
Debt Conversion, Original Debt, Amount															$ 600,000
Debt Conversion, Converted Instrument, Shares Issued | shares															600,001
Xcel Term Loan [Member]
Debt Instrument [Line Items]
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate						5.10%
Interest Expense, Debt						$ 308,000			310,000
Maximum Capital Expenditures of Guarantor and its Subsidiaries														2,650,000
Minimum Fixed Charge Ratio, Start Range							1	1.20
Minimum Fixed Charge Ratio, End Range						1	1
Minimum Liquidity Covenants						$ 5,000,000
Minimum Net Worth Required for Compliance							$ 90,000,000	$ 90,000,000						90,000,000
Long-term Debt, Total						24,000,000	25,250,000							25,250,000
Long-term Debt, Current Maturities, Total						4,750,000
Debt Instrument, Periodic Payment, Principal			$ 27,875,000
Xcel Term Loan [Member] | Scenario, Forecast [Member]
Debt Instrument [Line Items]
Maximum Capital Expenditures of Guarantor and its Subsidiaries													$ 700,000
Minimum Earnings Before Interest Taxes Depreciation And Amortization													9,000,000
Debt Instrument, Increase (Decrease) in Periodic Payment, Principal										$ 1,000,000			$ 1,000,000
C Wonder Earn-Out [Member]
Debt Instrument [Line Items]
Earn Out Payments						2,850,000
Loans Payable [Member]
Debt Instrument [Line Items]
Long-term Debt, Current Maturities, Total							4,000,000							4,000,000
Ripka Earn-Out [Member]
Debt Instrument [Line Items]
Royalty Earn Out Value						5,000,000
Earn Out Payments						3,050,000	3,050,000							3,050,000
Royalty Revenue, Total						1,000,000
Long-term Debt, Total						$ 3,780,000
Floor Price Per Share for Conversion of Debt | $ / shares						$ 7
Decrease In Maximum Amount of Earn-Out Consideration	$ 375,000
Earn-Out Consideration Payable in Cash	$ 175,000
Ripka Earn-Out [Member] | Scenario, Forecast [Member]
Debt Instrument [Line Items]
Long-term Debt, Principal Payments												$ 200,000
Earn-Out Consideration Payable in Cash																$ 100,000	$ 100,000
Royalty Income, Nonoperating											$ 6,000,000	$ 6,000,000
IM Seller Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount					$ 7,377,000
Stated Interest Rate on Note Payable					0.25%
Subordinated Borrowing, Interest Rate					9.25%
Debt Instrument, Unamortized Discount					$ 1,740,000
Imputed Annual Interest Rate					9.00%
Initial Outstanding Value of Long-term Debt or Borrowing					$ 5,637,000
Initial Prepaid Interest					$ 123,000
Exercise Price of Common Stock | $ / shares				$ 4.50
Interest Expense, Debt						$ 20,000			$ 72,000
Long-term Debt, Current Maturities, Total						$ 1,443,000
Debt Instrument Amended Description						(1) revise the maturity date to March 31, 2019, (2) require six semi-annual principal and interest installment payments of $750,000, commencing on September 30, 2016 and ending on March 31, 2019, (3) revise the stated interest rate to 2.236% per annum, (4) allow for optional prepayments at any time at the Companys discretion without premium or penalty, and (5) require that all payments of principal and interest be made in cash. Management assessed and determined that this amendment represented a debt modification and, accordingly, no gain or loss was recorded.
Debt Instrument, Maturity Date		Mar. 31, 2019
Judith Ripka Brand [Member]
Debt Instrument [Line Items]
Gain on Reduction of Contingent Obligations														3,410,000
Business Combination, Contingent Consideration, Liability							$ 380,000							$ 380,000				$ 3,780,000

Stockholders' Equity (Details)

Stockholders' Equity (Details)	3 Months Ended
	Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected Volatility Rate, Minimum	33.80%
Expected Volatility Rate, Maximum	35.20%
Expected Dividend Yield	0.00%
Risk-Free Interest Rate, Minimum	1.55%
Risk-Free Interest Rate, Maximum	2.02%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected Life (Term)	3 years 3 months
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected Life (Term)	5 years 5 months 1 day

Stockholders' Equity (Details 1

Stockholders' Equity (Details 1) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	2,436,000
Number of Options, Granted	800,000
Number of Options, Canceled	0
Number of Options, Exercised	0
Number of Options, Expired/Forfeited	(7,000)
Number of Options, Outstanding, Ending Balance	3,229,000	2,436,000
Number of Options, Exercisable at December 31, 2016	811,670
Weighted Average Exercise Price, Outstanding, Beginning Balance	$ 5.98
Weighted-Average Exercise Price, Granted	4.66
Weighted-Average Exercise Price Canceled	0
Weighted-Average Exercise Price, Exercised	0
Weighted-Average Exercise Price, Expired/Forfeited	5.8
Weighted Average Exercise Price, Outstanding, Ending Balance	5.66	$ 5.98
Weighted-Average Exercise Price, Exercisable at December 31, 2016	$ 6.01
Weighted Average Remaining Contractual Life (in years)	4 years 9 months 4 days	4 years 4 months 17 days
Exercisable Weighted Average Remaining Contractual Life (in years)	3 years 10 months 10 days
Aggregate Intrinsic Value, Outstanding	$ 0	$ 0
Aggregate Intrinsic Value, Exercisable	$ 0

Stockholders' Equity (Details 2

Stockholders' Equity (Details 2)	3 Months Ended
	Mar. 31, 2017$ / sharesshares
Number of Options
Granted	800,000
Employee Stock Option [Member]
Number of Options
Beginning Balance	2,294,667
Granted	800,000
Vested	(670,337)
Forfeited or Canceled	(7,000)
Ending Balance	2,417,330
Weighted Average Grant Date Fair Value
Beginning Balance | $ / shares	$ 1.39
Granted | $ / shares	1.09
Vested | $ / shares	1.49
Forfeited or Canceled | $ / shares	1.49
Ending Balance | $ / shares	$ 1.31

Stockholders' Equity (Details 4

Stockholders' Equity (Details 4) - Restricted Stock [Member] - $ / shares	1 Months Ended		3 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Restricted Shares, Outstanding, Beginning Balance		3,171,685	3,171,685
Number of Restricted Shares, Granted		50,000	98,000
Number of Restricted Shares, Canceled			0
Number of Restricted Shares, Vested	25,000		(683,251)
Number of Restricted Shares, Expired/Forfeited			(750)
Number of Restricted Shares, Outstanding, Ending Balance			2,585,684
Weighted-Average Exercise Price, Outstanding, Beginning Balance		$ 5.12	$ 5.12
Weighted-Average Grant Date Fair Value, Granted			3.29
Weighted-Average Grant Date Fair Value, Canceled			0
Weighted-Average Grant Date Fair Value, Vested			4.23
Weighted-Average Grant Date Fair Value, Expired/Forfeited			5.8
Weighted-Average Exercise Price, Outstanding, Ending Balance			$ 5.28

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	1 Months Ended					3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2017	Jan. 31, 2017	Jan. 24, 2017	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross						800,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price						$ 4.66
Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense						$ 302,000	$ 18,000
Non Management Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross						150,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price						$ 2.70
Non Management Directors [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage						50.00%
Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross					500,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price					$ 5
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 3,040,000			$ 3,040,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition						2 years 9 months 7 days
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense						$ 781,000	$ 1,194,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 1,530,000			$ 1,530,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition						1 year 8 months 5 days
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Granted				50,000		98,000
Restricted Stock [Member] | Non Management Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			48,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			2 years
Restricted Stock [Member] | Non Management Directors [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%	50.00%
Restricted Stock [Member] | Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures				50,000
2011 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			5,532,131			5,532,131
Common Stock, Capital Shares Reserved for Future Issuance			10,727,874			10,727,874
Common Stock, Eligible for Issuance			13,000,000			13,000,000
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Warrants Outstanding Number			1,966,743			1,966,743		1,966,743
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price			$ 6.76			$ 6.76
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms						2 years 6 months 22 days		2 years 9 months 22 days

Earnings Per Share (Details)

Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Employee Stock Option [Member] | Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options and warrants	5,195,743	3,266,500

Earnings Per Share (Details Tex

Earnings Per Share (Details Textual) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted Average Number of Shares Outstanding, Basic	18,674,943	18,458,748

Income Tax (Details Textual)

Income Tax (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Taxes [Line Items]
Effective Income Tax Rate, Continuing Operations	800.00%	53.00%
Income Tax Expense (Benefit)	$ 456	$ (51)
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent	737.00%
Effective Income Tax Rate Reconciliation Permanent Differences, Percent	29.00%	19.00%

Related Party Transactions (Det

Related Party Transactions (Details Textual) - USD ($)	1 Months Ended				3 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jan. 30, 2017	Dec. 22, 2014	Mar. 31, 2017	Mar. 31, 2016	Apr. 30, 2017	Sep. 01, 2015
Related Party Transaction [Line Items]
Royalty Expense					$ 9,000	$ 34,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		50,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		25,000
Licensing Agreements [Member]
Related Party Transaction [Line Items]
Operating Leases, Future Minimum Payments Receivable, in March 31, 2017								$ 190,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2018								750,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2019								750,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2020								1,500,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2021								$ 1,750,000
License Expiration Date				Dec. 31, 2019
Percentage Of Royalties					50.00%
Jones Texas, Inc [Member]
Related Party Transaction [Line Items]
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation					25,000
Consulting Fees For Period			$ 75,000
Due to Other Related Parties							$ 75,000
Jones Texas, Inc [Member] | Scenario, Forecast [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, Common Stock	28,334
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	25,000
Benjamin Malka [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage				25.00%
Lord & Taylor [Member]
Related Party Transaction [Line Items]
Royalty Expense					$ 1,000,000

Facility Exit Costs (Details)

Facility Exit Costs (Details) - Facility Exit Costs [Member] $ in Thousands	3 Months Ended
	Mar. 31, 2017USD ($)
Restructuring Cost and Reserve [Line Items]
Balance as of January 1, 2017	$ 783
Cash payments, net	(26)
Adjustment to liability (revision to estimated cash flows)	(25)
Accretion	5
Balance as of March 31, 2017	$ 737

Facility Exit Costs (Details Te

Facility Exit Costs (Details Textual) - Facility Exit Costs [Member] - USD ($)	3 Months Ended
	Mar. 31, 2017	Jun. 30, 2016	Dec. 31, 2016
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 648,000
Restructuring Reserve	$ 737,000		$ 783,000
Restructuring Reserve, Current	157,000
Restructuring Reserve, Noncurrent	$ 580,000
Facility Exit Costs Payable period	approximately 5 years, through February 2022